Taken together, those data [122,137,140,194,195,196,197,198,199,200] indicate a real possibility of the usage of GRP78 gene-silencing vectors against breast cancer, and as such an approach enables to sensitization of this malignancy to chemotherapy, antiestrogen therapy and radiotherapy. The gene discussed is HSPA5; the disease is breast carcinoma.